Speaker illustration

Doctor Andreas Xanthopoulos

University General Hospital of Larissa, Larissa (Greece)

Member of:

Heart Failure Association

Doctor Andreas Xanthopoulos MD, PhD, FACC, FHFSA is currently working as a consultant cardiologist in the University Hospital of Larissa, Greece. His clinical activities include heart failure and intensive care. His research is focused on heart failure and he has successfully completed a fellowship in advanced heart failure (Kauffman Center for Heart Failure, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, USA). Dr Xanthopoulos has authored several papers and book chapters. He is a reviewer in several journals such as Circulation, Eur J Heart Fail, Am J Transplant, Eur J Prev Cardiol, Heart Fail Rev, Cardiovasc Diabetol, ESC Heart Fail, etc. He is a member of the European Society of Cardiology and Echocardiography Association, Heart Failure Association of ESC, Working Group of Heart Failure, Hellenic Cardiological Society, European Association of Preventive Cardiology, American Colllege of Cardiology (Fellow) and Heart Failure Society of America (Fellow).

Postimplant phosphodiesterase type 5 inhibitor use in contemporary centrifugal flow left ventricular assist devices

Event: ESC Congress 2021 - The Digital Experience

Topic: Ventricular Assist Devices

Session: Latest Science in Heart Failure


Comorbidity burden can discriminate chronic heart failure with preserved and reduced but not with mid-range ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome


Cognitive dysfunction.

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Other

Session: How to manage psychosocial and CNS disorders in Heart Failure


A novel score for early risk stratification in acute heart failure


Topic: Acute heart failure (other)

Session: Acute heart failure


Red blood cell distribution width longitudinal changes in acute heart failure patients: a prospective study


Topic: Prognosis (using biomarkers)

Session: Biomarkers


This platform is supported by

logo Novo Nordisk